These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2654314)

  • 1. [New aspects of the pharmacology of pentoxifylline].
    Lenoble Giovannangeli M
    J Mal Vasc; 1989; 14 Suppl A():35-41. PubMed ID: 2654314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor.
    Hammerschmidt DE; Kotasek D; McCarthy T; Huh PW; Freyburger G; Vercellotti GM
    J Lab Clin Med; 1988 Aug; 112(2):254-63. PubMed ID: 2840477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentoxifylline in vitro reverses neutrophil chemotactic deficiency induced by interleukin-2 treatment.
    Fossat C; Sainty D; Stoppa AM; Maraninchi D; Juhan-Vague I
    Nouv Rev Fr Hematol (1978); 1992; 34 Suppl():S61-4. PubMed ID: 1340531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pentoxifylline].
    Paradowski PT; Zeman K
    Postepy Hig Med Dosw; 1995; 49(2):201-20. PubMed ID: 8657627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of the potentiation of thrombolysis by pentoxifylline (Trental).
    Ambrus JL; Ambrus CM; Mahfzah M; Markus JA; Klein E; Gastpar H
    J Med; 1987; 18(5-6):265-76. PubMed ID: 3505256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline.
    Sullivan GW; Carper HT; Novick WJ; Mandell GL
    Infect Immun; 1988 Jul; 56(7):1722-9. PubMed ID: 2838424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pentoxifylline on polarization and migration of human leukocytes.
    Domínguez-Jiménez C; Sancho D; Nieto M; Montoya MC; Barreiro O; Sánchez-Madrid F; González-Amaro R
    J Leukoc Biol; 2002 Apr; 71(4):588-96. PubMed ID: 11927644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Free radicals and antioxidants: physiology, human pathology and therapeutic aspects (part II)].
    Sahnoun Z; Jamoussi K; Zeghal KM
    Therapie; 1998; 53(4):315-39. PubMed ID: 9806002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pentoxifylline on neutrophil behaviour: stimulation of movement without adhesion changes.
    Crocket KV; Lackie JM; Rogers AA
    Biomed Pharmacother; 1988; 42(2):117-20. PubMed ID: 3167164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of pentoxifylline in septic shock--new pharmacologic aspects of an established drug.
    Schönharting MM; Schade UF
    J Med; 1989; 20(1):97-105. PubMed ID: 2651550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The biology of fibrinogen. The role of pentoxifylline].
    Soria J; Soria C
    J Mal Vasc; 1989; 14 Suppl A():25-8. PubMed ID: 2654312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentoxifylline -- a biomedical profile.
    Müller R
    J Med; 1979; 10(5):307-29. PubMed ID: 393789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroblastoma cell-mediated leukocyte chemotaxis: lineage-specific differentiation of interleukin-8 expression.
    Yang KD; Shaio MF; Wang CL; Wu NC; Stone RM
    Exp Cell Res; 1994 Mar; 211(1):1-5. PubMed ID: 8125147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte activation study during occlusive arterial disease of the lower limb: effect of pentoxifylline infusion.
    Fossat C; Fabre D; Alimi Y; Bienvenu J; Aillaud MF; Lenoble M; Juhan-Vague I; Juhan C
    J Cardiovasc Pharmacol; 1995; 25 Suppl 2():S96-100. PubMed ID: 8699873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The haemorheological and antithrombotic potential of pentoxifylline ('Trental'): a review.
    Schönharting M; Musikić P; Müller R
    Pharmatherapeutica; 1988; 5(3):159-69. PubMed ID: 3283776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cell associated platelet-activating factor (PAF), a costimulatory intermediate in TNF-alpha-induced H2O2 release by adherent neutrophil leukocytes.
    von Asmuth EJ; Buurman WA
    J Immunol; 1995 Feb; 154(3):1383-90. PubMed ID: 7529802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte modulation of endothelial leukocyte adhesion molecules.
    Weill D; Wautier JL; Dosquet C; Wautier MP; Carreno MP; Boval B
    J Lab Clin Med; 1995 Jun; 125(6):768-74. PubMed ID: 7539477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pentoxifylline on the different steps during adhesion and transendothelial migration of flowing neutrophils.
    Bahra PS; Rainger GE; Wautier JL; Nash GB
    Cell Biochem Funct; 2001 Dec; 19(4):249-57. PubMed ID: 11746205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of fibrinolysis activation on leukocyte adhesiveness. Preliminary report.
    Lukjan H; Szpak A; Kwiatkowski M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):191-7. PubMed ID: 2427401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of chemotaxis and protection of mice from infection.
    Sullivan GW; Patselas TN; Redick JA; Mandell GL
    Trans Assoc Am Physicians; 1984; 97():337-45. PubMed ID: 6535350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.